202 related articles for article (PubMed ID: 37210571)
61. Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis.
Lumetti F; Barone L; Alfieri C; Silva M; Serra V; Delsante G; Sverzellati N; Ariani A
Acta Biomed; 2015 Sep; 86(2):142-8. PubMed ID: 26422428
[TBL] [Abstract][Full Text] [Related]
62. Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease.
Kreuter M; Hoffmann-Vold AM; Matucci-Cerinic M; Saketkoo LA; Highland KB; Wilson H; Alves M; Erhardt E; Schoof N; Maher TM
Rheumatology (Oxford); 2023 Feb; 62(SI):SI43-SI53. PubMed ID: 35640959
[TBL] [Abstract][Full Text] [Related]
63. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
Georges C; Chassany O; Mouthon L; Tiev K; Toledano C; Meyer O; Marjanovic Z; Heneggar C; Papo T; Crickx B; Sereni D; Cabane J; Farge D
Clin Rheumatol; 2005 Feb; 24(1):3-10. PubMed ID: 15674652
[TBL] [Abstract][Full Text] [Related]
64. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis.
Yang H; Xu D; Li MT; Yao Y; Jin M; Zeng XF; Qian JM
J Dig Dis; 2019 May; 20(5):256-261. PubMed ID: 30838807
[TBL] [Abstract][Full Text] [Related]
65. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
66. Factors associated with the 6-minute walk distance in patients with systemic sclerosis.
Sanges S; Giovannelli J; Sobanski V; Morell-Dubois S; Maillard H; Lambert M; Podevin C; Lamblin N; De Groote P; Bervar JF; Perez T; Matran R; Rémy-Jardin M; Hatron PY; Hachulla É; Launay D
Arthritis Res Ther; 2017 Dec; 19(1):279. PubMed ID: 29246248
[TBL] [Abstract][Full Text] [Related]
67. Hand functions in systemic sclerosis and rheumatoid arthritis and influence on clinical variables.
Erol K; Gok K; Cengiz G; Ozgocmen S
Int J Rheum Dis; 2018 Jan; 21(1):249-252. PubMed ID: 28322506
[TBL] [Abstract][Full Text] [Related]
68. Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.
Zekovic A; Damjanov N
Rheumatol Int; 2017 May; 37(5):735-741. PubMed ID: 28271157
[TBL] [Abstract][Full Text] [Related]
69. Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants.
van Leeuwen NM; Ciaffi J; Liem SIE; Huizinga TWJ; de Vries-Bouwstra JK
Rheumatology (Oxford); 2021 Aug; 60(8):3646-3655. PubMed ID: 33401302
[TBL] [Abstract][Full Text] [Related]
70. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms.
Danieli E; Airò P; Bettoni L; Cinquini M; Antonioli CM; Cavazzana I; Franceschini F; Cattaneo R
Clin Rheumatol; 2005 Feb; 24(1):48-54. PubMed ID: 15300468
[TBL] [Abstract][Full Text] [Related]
71. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Airò P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E;
Arthritis Rheumatol; 2019 Sep; 71(9):1553-1570. PubMed ID: 30969034
[TBL] [Abstract][Full Text] [Related]
72. Serum-soluble ST2 and systemic sclerosis arthropathy.
Colalillo A; Pellicano C; Rosato E
Clin Rheumatol; 2023 Mar; 42(3):871-877. PubMed ID: 36098853
[TBL] [Abstract][Full Text] [Related]
73. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
Park EH; Strand V; Oh YJ; Song YW; Lee EB
Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
[TBL] [Abstract][Full Text] [Related]
74. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre.
Thoua NM; Bunce C; Brough G; Forbes A; Emmanuel AV; Denton CP
Rheumatology (Oxford); 2010 Sep; 49(9):1770-5. PubMed ID: 20530510
[TBL] [Abstract][Full Text] [Related]
75. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
[TBL] [Abstract][Full Text] [Related]
76. Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis.
Morrisroe K; Stevens W; Huq M; Sahhar J; Ngian GS; Zochling J; Roddy J; Proudman SM; Nikpour M;
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):130-137. PubMed ID: 28516877
[TBL] [Abstract][Full Text] [Related]
77. Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study.
Singh MK; Clements PJ; Furst DE; Maranian P; Khanna D
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):176-83. PubMed ID: 22012885
[TBL] [Abstract][Full Text] [Related]
78. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
[TBL] [Abstract][Full Text] [Related]
79. The assessment of malnutrition and severity of gastrointestinal disease by using symptom-based questionnaires in systemic sclerosis: is it related to severe organ involvement or capillary rarefaction at microcirculation?
Yalcinkaya Y; Erturk Z; Unal AU; Kaymaz Tahra S; Pehlivan O; Atagunduz P; Direskeneli H; Inanç N
Clin Exp Rheumatol; 2020; 38 Suppl 125(3):127-131. PubMed ID: 32141434
[TBL] [Abstract][Full Text] [Related]
80. Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis.
Ng X; Thumboo J; Low AH
Int J Rheum Dis; 2012 Jun; 15(3):268-76. PubMed ID: 22709488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
